Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 14:13:871945.
doi: 10.3389/fendo.2022.871945. eCollection 2022.

Quantitative Proteomics Reveals That a Prognostic Signature of the Endometrium of the Polycystic Ovary Syndrome Women Based on Ferroptosis Proteins

Jian Zhang  1 , Nan Ding  1 , Wenhu Xin  1 , Xin Yang  1 , Fang Wang  1
Affiliations

Quantitative Proteomics Reveals That a Prognostic Signature of the Endometrium of the Polycystic Ovary Syndrome Women Based on Ferroptosis Proteins

Jian Zhang et al. Front Endocrinol (Lausanne). .

Abstract

Objective: We aimed to study the relationship between ferroptosis proteins and reproductive outcomes of infertile patients with PCOS and construct the related prognostic model.

Methods: These endometrium samples of the study were collected from 33 women with PCOS and 7 control women with successful pregnancies at the Reproductive Center of Lanzhou University Second Hospital, September 2019 to September 2020. The 40 patients' endometrium was identified the differentially expressed proteins (DEPs) using liquid chromatography tandem mass spectrometry. The Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis and Gene Ontology (GO) showed that the DEPs related pathways and functions between PCOS and controls. Subsequently, univariate Cox regression analysis and Lasso regression were used to identifying independent prognostic ferroptosis proteins, which were utilized to establish a prognostic model. Then the performance of the prognostic model was evaluated by receiver operating characteristic curve (ROC) and decision curve analysis (DCA). Then clinical data and prognostic model were used to predict the reproductive outcomes of PCOS patients by constructing the nomograms. Finally, we performed the single sample gene set enrichment analysis (ssGSEA) to explore the correlation between risk scores and immune status.

Results: A total of 5331 proteins were identified, 391 proteins were differentially expressed in the PCOS and controls. The KEGG analysis revealed that the ferroptosis pathway was significantly different between PCOS and controls. 5 ferroptosis proteins (GPX4, DPP4, G6PD, PCBP1, and PCBP2) prognostic model (FerSig) was constructed via Cox regression and Lasso regression. Patients were separated into high and low-risk groups according to the FerSig. Kaplan-Meier curve showed that patients in the low-risk group had much better reproductive outcomes than those in the high-risk group. The DCA showed that the risk score was an independent predictive factor for reproductive outcomes. Compared with clinical data, ROC curve analysis indicated the FerSig proteins as a potential diagnostic and prognostic factor in PCOS patients. Functional analysis revealed that the FerSig proteins and immune microenvironment were correlated to the prognosis of PCOS.

Conclusion: The prognostic model focused on the FerSig proteins could predict the reproductive outcomes of PCOS patients with decreased endometrial receptivity, and provided theoretical basis for individualized treatment.

Keywords: PCOS; endometrial proteins; ferroptosis; prognostic model; quantitative proteomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Protein identification analysis and clinical data evaluation.
Figure 2
Figure 2
Identification and functional enrichment of DEPs.
Figure 3
Figure 3
Ferroptosis relative proteins differential analysis.
Figure 4
Figure 4
Establishment and evaluation of the FerSig risk prognostic model.
Figure 5
Figure 5
Immune microenvironment analysis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Visser JA. The Importance of Metabolic Dysfunction in Polycystic Ovary Syndrome. Nat Rev Endocrinol (2021) 17:77–8. doi: 10.1038/s41574-020-00456-z - DOI - PubMed
    1. Escobar-Morreale HF. Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment. Nat Rev Endocrinol (2018) 14:270–84. doi: 10.1038/nrendo.2018.24 - DOI - PubMed
    1. Strowitzki T. Advanced Diagnosis of Polycystic Ovary Syndrome-New Prediction Models With Standard Parameters. Fertil Steril (2021) 115:92–3. doi: 10.1016/j.fertnstert.2020.09.031 - DOI - PubMed
    1. Zippl AL, Seeber B, Wildt L. Insulin Resistance: Still an Underestimated Factor in Polycystic Ovary Syndrome? Fertil Steril (2021) 115:1447–8. doi: 10.1016/j.fertnstert.2021.03.020 - DOI - PubMed
    1. Fernandez RC, Moore VM, Rumbold AR, Whitrow MJ, Avery JC, Davies MJ. Diagnosis Delayed: Health Profile Differences Between Women With Undiagnosed Polycystic Ovary Syndrome and Those With a Clinical Diagnosis by Age 35 Years. Hum Reprod (2021) 36:2275–84. doi: 10.1093/humrep/deab101 - DOI - PMC - PubMed

Publication types